$1529 | SAVE $270 | Single User
$4587 | SAVE $810 | Enterprise License

Colitis - Pipeline Drugs and Companies, Q2 2019

Colitis - Pipeline Drugs and Companies, Q2 2019
[Lowest Price Guaranteed: $1,529]

Published by VPA Research: 08 Apr 2019 | 235124 | In Stock
Related Topics: Healthcare

Introduction

Summary

Colitis pipeline research report is a part of our 300+ Pharmaceutical and Healthcare disease pipeline report series. It provides detailed insights into Colitis R&D activities including pipeline candidates, grants, developments, investments, technological advancements, and progress.

Extensive Coverage of Pipeline Candidates

The Colitis report covers all the pre-clinical compounds and clinical compounds under evaluation for treatment of Colitis as of 2019. All preclinical, research, discovery, pre registration, phase 1, phase 2, and phase 3 trials active are included in the study.

Over 10 descriptive details provided for each Pipeline Product

Complete analysis of therapeutics for treatment of Colitis with details of current status of development, pipeline phase, drug target, mechanism of action (MoA), route of administration (RoA), participating companies, originator, collaborators and molecule type are included. The study also covers the historic developments, pharmacological action and recent developments associated with each drug.

Companies participating in Colitis pipeline Profiled in detail

Key players actively participating in Colitis pipeline are profiled along with their R&D progress in Colitis treatment are provided. Companies /Universities /Institutes participating as originators, collaborators, licensors, investors, and marketing or developing companies are detailed in the report. Further, for all the developing companies, detailed profile is also provided.

Information Sourced from in-house Proprietary Databases

The report is developed using information from in-house database developed over years through daily updates from company reports, websites, events, conferences, news, announcements, clinical trial registries, regulatory authorities, universities and industry associations.

Report assists users in taking actionable steps

Colitis pipeline report enables users to gain clear understanding into large and small companies participating in the pipeline and detailed insights into their product portfolio. The guide presents also available opportunities for new business in Colitis treatment pipeline.

The report includes:

• The research work provides comprehensive overview of Colitis pipeline and treatment landscape

• Complete list of drug candidates from discovery to pre-registration phases are analyzed

• Companies and universities participating in the pipeline are analyzed in detail along with their drug development product portfolio

• Detailed drug profiles of Colitis pipeline compounds including status, phase, mechanism of action, route of administration, originators, licensing and collaborating companies, grants, technological advancements and investments are detailed

• Research and Development progress and trial details, results wherever available, are also included in the Colitis pipeline study

• All recent news and developments related to Colitis drugs are provided

Table of Contents
for Colitis - Pipeline Drugs and Companies, Q2 2019

  • 1. Introduction

    1.1. Pipeline Snapshot, 2019

    1.2. Overview Pipeline Activities in 2019

    2. Colitis Disease Overview

    3. Colitis R&D Pipeline Trends

    3.1. Pipeline Drugs under development by phase, 2019

    3.2. Pipeline Drugs by Mechanism of Action, 2019

    3.3. Pipeline Drugs by Route of Administration, 2019

    3.4. Pipeline Drugs by Company, 2019

    3.5. Pipeline Drugs by Molecule Type, 2019

    4. Colitis Pre-clinical and Discovery Phase Drug Profiles

    4.1. Drug Name/Alternative Names

    4.2. Originator

    4.3. Licensor/Developer/Collaborators

    4.4. Class

    4.5. Mechanism of Action

    4.6. Route of Administration

    4.7. Orphan Drug Status

    4.8. New Molecular Entity

    4.9. Current Status

    4.10. Trial Landscape

    4.11. Development History

    5. Colitis Clinical Phase Drug Profiles

    5.1. Drug Name/Alternative Names

    5.2. Originator

    5.3. Licensor/Developer/Collaborators

    5.4. Class

    5.5. Mechanism of Action

    5.6. Route of Administration

    5.7. Orphan Drug Status

    5.8. New Molecular Entity

    5.9. Current Status

    5.10. Trial Landscape

    5.11. Development History

    6. Company Profiles

    6.1. Colitis companies

    6.1.1. Business Profile

    6.1.2. Pipeline Products

    6.1.3. Colitis Activities

    7. Recent News Landscape

    8. Appendix

    8.1. Sources and Research Methodology

    8.2. Publisher Expertise

    8.3. Database and Custom Services

Additional Details

Publisher

VPA Research

Publisher Information

VPAResearch pipeline research is one of the reputed and trusted series worldwide. Our coverage includes- 42000+ pipeline drugs in our internal databases All databases updated daily by our in-house experts crawling through  10,000+ sources. In-depth analysis of end-to-end pipeline development included

Reference

235124 | VPA0419P005

Number of Pages

100

Report Format

PDF

VPA Research Reports

Related Reports

TitleDate PublishedPrice fromMore Details
SAVE 15% today! Crohn's & Colitis Foundation of America - Pharmaceuticals & Healthcare - Deals and Alliances Profile
SummaryCrohn's & Colitis Foundation of America (CCFA) is a healthcare foundation which offers treatm...
25 Nov 2016 by Global Data USD $213 (normally
USD $251)
More Info
SAVE 15% today! Global Ulcerative Colitis Partnering 2010-2016
The Global Therapy Partnering Terms and Agreements since 2010 report provides understanding and acce...
01 Nov 2016 by Current Partnering USD $1,271 (normally
USD $1,495)
More Info
SAVE 15% today! Global Ulcerative Colitis Partnering 2010-2016
The Global Therapy Partnering Terms and Agreements since 2010 report provides understanding and acce...
01 Oct 2016 by Current Partnering USD $1,271 (normally
USD $1,495)
More Info
SAVE 15% today! Ulcerative Colitis Global Clinical Trials Review, H2, 2016
Ulcerative Colitis Global Clinical Trials Review, H2, 2016SummaryGlobalData's clinical trial report,...
28 Sep 2016 by Global Data USD $2,125 (normally
USD $2,500)
More Info
SAVE 15% today! Crohn's & Colitis Foundation of America - Pharmaceuticals & Healthcare - Deals and Alliances Profile
SummaryCrohn's & Colitis Foundation of America (CCFA) is a healthcare foundation that offers treatme...
27 Apr 2016 by Global Data USD $213 (normally
USD $251)
More Info
SAVE 15% today! Colitis Global Clinical Trials Review, H1, 2016
Colitis Global Clinical Trials Review, H1, 2016SummaryGlobalData's clinical trial report, “Colitis G...
11 Mar 2016 by Global Data USD $2,125 (normally
USD $2,500)
More Info
SAVE 15% today! Crohn's & Colitis Foundation of America - Pharmaceuticals & Healthcare - Deals and Alliances Profile
SummaryCrohn's & Colitis Foundation of America (CCFA) is a healthcare foundation that offers treatme...
09 Mar 2016 by Global Data USD $213 (normally
USD $251)
More Info
SAVE 15% today! Ulcerative Colitis: Update Bulletin [Feb 2016]
IntroductionGain new KOL insights on the latest events happening in Ulcerative Colitis. Topics cover...
01 Feb 2016 by FirstWord Pharma USD $846 (normally
USD $995)
More Info
SAVE 15% today! Ulcerative Colitis: KOL Insight
Introductionipeline drugs are poised to reshape the way doctors treat ulcerative colitis (UC). But w...
01 Dec 2015 by FirstWord Pharma USD $6,715 (normally
USD $7,900)
More Info
SAVE 15% today! Ulcerative Colitis: KOL Insight
IntroductionThe Ulcerative Colitis (UC) treatment market is already undergoing radical change as new...
03 Dec 2014 by FirstWord Pharma USD $6,715 (normally
USD $7,900)
More Info

This report is published by VPA Research

VPAResearch pipeline research is one of the reputed and trusted series worldwide. Our coverage includes- 42000+ pipeline drugs in our internal databases All databases updated daily by our in-house experts crawling through  10,000+ sources. In-depth analysis of end-to-end pipeline development included

Download Free Report Summary PDF

Colitis - Pipeline Drugs and Companies, Q2 2019 | Download PDF Summary

Download our FREE report summary PDF. It contains all the information on these web pages, plus a Proforma Invoice request form, should you need it to satisfy your company's internal order procedures.

Ordering Information

Orders are processed immediately and you will be notified of the despatch date on confirmation of your order.

Accepted Card Types

Payment

Buy now using our secure payment system.

We Stock...